MEA Ophthalmology Market - Industry Trends and Forecast to 2030
The Middle East & Africa Ophthalmology market is projected to register a substantial CAGR of 4.6 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentations
Middle East & Africa Ophthalmology Market, By Product Type (Device, Drugs, and Others), Diseases (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Others), Prescription Mode (Generic, and Branded), Drug Type (Prescription, and Over the Counter (OTC)), Route of Administration (Oral, Topical, Injectables, Local Ocular, and Others) End User (Hospitals, Clinics, Home Healthcare, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Israel, Kuwait, and Rest of Middle East and Africa), Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the Middle East & Africa Ophthalmology market are:
• Rising prevalence of ophthalmic disorders & ocular pains
• Increasing unhygienic & sedentary lifestyle
• The rise in traumatic injuries
• The rise in the geriatric population
Market Players
Some of the key market players for the Middle East & Africa Ophthalmology market are listed below:
• Johnson & Johnson Services, Inc.
• Novartis AG
• Bausch & Lomb Incorporated
• AbbVie Inc.
• Alcon
• Santen Pharmaceutical Co., Ltd.
• Others
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook